Richard Whitley

Richard Whitley

Director/Board Member chez VIRIOS THERAPEUTICS, INC.

Fortune : 335 $ au 31/03/2024

78 ans
Health Technology
Commercial Services
Consumer Services

Profil

Richard J.
Whitley
is the founder of Treovir LLC (2019) and Alabama Drug Discovery Alliance.
He is currently a Director at Primus Pharmaceuticals, Inc., an Independent Director at Virios Therapeutics, Inc. (2020-present), a Director at FermaVir Pharmaceuticals LLC, Co-Director-Pediatric Infectious Diseases at Washington University School of Medicine, a Member of the Association of American Physicians, a Member of the American Society of Clinical Investigation, a Professor at The University of Alabama at Birmingham, and a Member-Supervisory Board at Leyden Laboratories B.V.
Dr. Whitley's former positions include Chairman-Scientific Councilors at Centers for Disease Control & Prevention (2000-2012), Chairman-HIV Vaccine Data Safety at National Institute of Allergy & Infectious Diseases, Independent Director at Gilead Sciences, Inc. (2008-2021), Director at Gilead Connecticut, Inc., President of Infectious Diseases Society of America, and President of The International Society for Antiviral Research.
Dr. Whitley's education includes an undergraduate degree and a doctorate from Duke University and a doctorate from George Washington University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/02/2024 700 ( 0,00% ) 335 $ 31/03/2024

Postes actifs de Richard Whitley

SociétésPosteDébut
VIRIOS THERAPEUTICS, INC. Director/Board Member 21/12/2020
Director/Board Member 16/08/2005
Director/Board Member -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Founder -
Washington University School of Medicine Corporate Officer/Principal -
The University of Alabama at Birmingham Corporate Officer/Principal -
Director/Board Member -
Tous les postes actifs de Richard Whitley

Anciens postes connus de Richard Whitley

SociétésPosteFin
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Voir l'expérience en détail de Richard Whitley

Formation de Richard Whitley

Duke University Doctorate Degree
George Washington University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Richard Whitley

Relations

100 +

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
GILEAD SCIENCES, INC.

Health Technology

VIRIOS THERAPEUTICS, INC.

Health Technology

Entreprise privées12

Retail Trade

Health Technology

Government

Health Technology

Commercial Services

American Society of Clinical Investigation

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

Commercial Services

Health Technology

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Richard Whitley